Catalyst Wire Dossier Catalyst Wire Dossier

Apremilast (Otezla)

apremilast · Bristol Myers Squibb
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Apremilast (Otezla), covering 2013-10-21 to 2026-02-17. Get the full timeline:

Most recent: Clinical Trial Update: Randomized Double Blind Controlled Trial Comparing the Safety and Efficacy of Apremilast Versus Placebo in Severe Forms of Recurrent Aphthous Stomatitis [Phase 3]

See pricing